Trials / Sponsors / Turnstone Biologics, Corp.
Turnstone Biologics, Corp.
Industry · 5 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | A Study of TBio-4101 (TIL) and Pembrolizumab in Patients With Advanced Solid Tumors Breast Cancer, Colorectal Cancer, Uveal Melanoma | Phase 1 | 2023-01-17 |
| Terminated | Study of TBio-6517 Given Alone or in Combination With Pembrolizumab in Solid Tumors Solid Tumor, Microsatellite Stable Colorectal Cancer, HPV Positive Oropharyngeal Squamous Cell Carcinoma | Phase 1 | 2020-06-02 |
| Withdrawn | MG1-MAGEA3 With Ad-MAGEA3 and Pembrolizumab in Patients With Previously Treated Metastatic Melanoma or Cutaneo Metastatic Melanoma, Squamous Cell Skin Carcinoma | Phase 1 | 2020-02-15 |
| Terminated | This is a Trial of MG1-E6E7 With Ad-E6E7 and Atezolizumab in Patients With HPV Associated Cancers HPV-Associated Cancers | Phase 1 | 2018-06-21 |
| Completed | Oncolytic MG1-MAGEA3 With Ad-MAGEA3 Vaccine in Combination With Pembrolizumab for Non-Small Cell Lung Cancer P Non-Small Cell Lung Cancer | Phase 1 / Phase 2 | 2017-03-08 |